Fox Chase Cancer Center was formed in 1974 by the union of the American Oncologic Hospital, which was established in 1904, and the Institute for Cancer Research, based in 1927. Fox Chase became the NCI-designated comprehensive cancer center in 1974. An affiliate of the Temple University Health System because 2012, Fox Chase is a pancreatic cancer center also serves as the Cancer Plan for Temple University.
With an overall team of 2,400, the Center provides both patient care and research in more than 80 labs staffed by 325 physicians and scientists. The association with Temple has added significance to the cancer center with the addition of 50 research program members from multiple University Departments and the School of Medicine. Clinical, basic, and population research conducted by experts across areas subsequently enables the Center to interpret new research findings into medical programs that may develop models for better cancer care. Fox Chase Cancer Center offers the opportunity for involvement in clinical trials at the Center and out in the area, through its Extramural Research Program.
Research programs in the Center encompass Cancer Biology, Blood Cell Development and Function, Molecular Therapeutics, Cancer Epigenetics, and Cancer Prevention and Control. One of the prevention-related services offered is specific programs to assist people with family histories or other specific risks of ovarian and breast cancer, gastrointestinal cancer, melanoma, and prostate cancer.
READ: Does Caillou Have Cancer
Fox Chase has a rich scientific history as the center that found that the Philadelphia Chromosome, also has had two Nobel Prize winners. They are a founding member of the National Comprehensive Cancer Network, were named as the best location for researchers to operate in The Scientist, along with a top cancer clinic by US News & World Report